Diatherix logo

Diatherix

A unique laboratory providing accurate and actionable results in one day for infectious diseases and antibiotic resistance genes utilizing innovative molecular technologies, including proprietary TEM-PCR™. Eurofins Diatherix distinctions: - Delivers one-day results - Identifies bacteria regardless of recent antibiotic use - Offers simplicity of single-sample collection - Identifies difficult-to-culture pathogens - Yields a high level of sensitivity and specificity

Free account • No credit card • 5 profiles/day

Biotechnology Research 154 Employees Found Huntsville, United States Founded 2008 10 Similar Companies
154 Employees Found
93% Email Coverage
$57.0M Est Revenue
1 Office HQ
10 Similar Companies
Jun '26 Last Verified

Diatherix – Company Information

Biotechnology Research
Founded 2008
51-200 employees View all
601 Genome Way, Suite 2100, Huntsville, Alabama 35806, US
Diagnostics Infectious Disease Gastrointestinal Wounds Molecular Respiratory Infection STDs TEM-PCR COVID-19 Testing Skin and Soft Tissue

Frequently asked questions about Diatherix

What is Diatherix email format?

The widely used Diatherix email format is {first}{last} (e.g. johnsmith@eurofins-diatherix.com) with 75% adoption across the company.

What is Diatherix customer service number?

To contact Diatherix customer service number in your country click here to find.

Who is the CEO of Diatherix?

Dennis Grimaud is the CEO of Diatherix.

Who are the decision makers in Diatherix?

The decision makers in Diatherix are Dennis Grimaud, Brent K, Kim Tipton, etc. Click to Find Diatherix decision makers emails.

What types of infectious diseases does Eurofins Diatherix test for?

Eurofins Diatherix specializes in diagnostics for a wide range of infectious diseases, including gastrointestinal infections, respiratory infections, sexually transmitted diseases (STDs), and skin and soft tissue infections. Our proprietary TEM-PCR™ technology allows us to accurately detect pathogens quickly, providing actionable results within one day.

How does the TEM-PCR™ technology work?

TEM-PCR™ (Target Enrichment Multiplex Polymerase Chain Reaction) is an innovative molecular technology developed by Eurofins Diatherix that enhances the detection of infectious agents. It allows for the simultaneous amplification and detection of multiple pathogens from a single sample, significantly increasing sensitivity and specificity. This means we can provide rapid and accurate results, which are crucial for effective patient management.

What industries does Eurofins Diatherix serve?

Eurofins Diatherix serves a variety of industries, including healthcare facilities, laboratories, and public health organizations. Our services are particularly beneficial for hospitals, urgent care centers, and clinics that require rapid diagnostic testing for infectious diseases. We also support research institutions and pharmaceutical companies in their efforts to understand and combat infectious diseases and antibiotic resistance.

How quickly can I expect results from Eurofins Diatherix?

Eurofins Diatherix prides itself on providing accurate and actionable results within one day. Our advanced molecular technologies, including TEM-PCR™, enable us to process samples efficiently, ensuring that healthcare providers receive timely information to guide patient care and treatment decisions.

What types of samples does Eurofins Diatherix accept for testing?

We accept a variety of sample types for testing, including swabs from wounds, respiratory specimens (such as nasal swabs), stool samples for gastrointestinal testing, and other biological specimens as needed. Our laboratory is equipped to handle diverse sample types to ensure comprehensive testing for infectious diseases.

Is Eurofins Diatherix involved in COVID-19 testing?

Yes, Eurofins Diatherix offers COVID-19 testing as part of our commitment to public health. We utilize our advanced molecular testing capabilities to provide accurate and rapid results for COVID-19, helping to support healthcare providers and communities in managing the pandemic effectively.